Clinical and Molecular-Metabolic Trial of Perifosine for Recurrent/Progressive Malignant Gliomas.
Latest Information Update: 21 Oct 2020
At a glance
- Drugs Perifosine (Primary)
- Indications Astrocytoma; Glioblastoma; Glioma; Oligodendroglioma
- Focus Therapeutic Use
- 14 Nov 2019 Status changed from active, no longer recruiting to completed.
- 14 Nov 2019 Status changed from active, no longer recruiting to completed.
- 03 Jun 2019 Planned End Date changed from 1 May 2019 to 1 May 2020.